Lundbeck
HLUN-B.CO
#2596
Rank
A$10.02 B
Marketcap
A$10.57
Share price
0.63%
Change (1 day)
11.73%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): A$0.93

According to Lundbeck's latest financial reports the company's current EPS (TTM) is A$0.93. In 2024 the company made an earnings per share (EPS) of A$0.67 an increase over its 2023 EPS that were of A$0.52.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.9339.65%
2024A$0.6729.29%
2023A$0.5223.09%
2022A$0.4237.26%
2021A$0.31-84.61%
2020A$1.99-24.61%
2019A$2.64-42.06%
2018A$4.5640.7%
2017A$3.24146.26%
2016A$1.32-120.48%
2015A-$6.423231.32%
2014A-$0.19-115.78%
2013A$1.22-23.36%
2012A$1.59-48.01%
2011A$3.07-9.68%
2010A$3.4013.72%
2009A$2.9924.32%
2008A$2.40-6.05%
2007A$2.5681.77%
2006A$1.41-16.76%
2005A$1.69-17.58%
2004A$2.05